Summit Therapeutics Inc. (NASDAQ: SMMT) will host an earnings call on Monday, February 23, 2026, after market close, to discuss its fourth quarter and full year 2025 financial results and provide an operational update. A live webcast of the conference call will be accessible at 4:30 PM ET via their website, www.smmttx.com, with an archived edition available subsequently. Summit Therapeutics is an oncology biopharmaceutical company focused on developing medicinal therapies to improve quality and duration of life for patients.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Summit Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results & Operational Progress Call on February 23, 2026
Summit Therapeutics Inc. (NASDAQ: SMMT) will host an earnings call on Monday, February 23, 2026, after market close, to discuss its fourth quarter and full year 2025 financial results and provide an operational update. A live webcast of the conference call will be accessible at 4:30 PM ET via their website, www.smmttx.com, with an archived edition available subsequently. Summit Therapeutics is an oncology biopharmaceutical company focused on developing medicinal therapies to improve quality and duration of life for patients.